NECTRANT
US trademark, USPTO serial 99851200
"NECTRANT" is a registered US trademark filing (serial 99851200), owned by Glaxo Group Limited, filed May 28, 2026.
Get an email when this status changes
We email you about office actions, publication and registration for free, and we check after each USPTO data update.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Filing details
| Status | Registered |
| Serial number | 99851200 |
| Filing date | May 28, 2026 |
| Owner | Glaxo Group Limited (243 filings) |
| NICE classes | Class 5 |
Goods and services
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Source and method
Built from public USPTO trademark records via WikiTrademarks. We match by exact wording, whole-word, phonetic sound-alike, and fuzzy look-alike, scoped by NICE class. Data reflects the most recent USPTO import. Last updated November 19, 2026.
Cite this page: WikiTrademarks, "NECTRANT trademark (serial 99851200)", https://wikitrademarks.com/trademark/99851200/nectrant (accessed November 19, 2026).